Risk Factors for Shoulder Joint Motion Restriction

NCT ID: NCT05386641

Last Updated: 2022-05-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-15

Study Completion Date

2024-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In breast cancer patients, limitation of shoulder joint movement may occur following cancer treatment. Shoulder limitation causes a significant decrease in the patient's participation in activities of daily living. The aim of the study is to define these limitations, to evaluate in detail all the structures that cause the problem, and to determine the causes of the limitations in patients with shoulder joint movement limitation developed after breast cancer survivors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Survivors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Group

Breast cancer survivors with shoulder joint motion restriction

measurement of tissue stiffness (N/m)

Intervention Type OTHER

Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain

measurement of passive muscle tone (Hz)

Intervention Type OTHER

muscle tones will be measured with myotonPro on centers of coordination located along along the myofascial chain

measurement of creep of tissue

Intervention Type OTHER

creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain

measurement of the range of shoulder joint motion

Intervention Type OTHER

The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.

measurement of skin temperature

Intervention Type OTHER

measurements will be taken by the thermographic camera

measurement of pain

Intervention Type OTHER

Pain will be evaluated by visual analog scale (VAS)

measurement of pain pressure threshold

Intervention Type OTHER

Pain pressure threshold will be evaluated by a digital algometer

measurement of grip strength

Intervention Type OTHER

The grip strength of both hand will be evaluated by "hand-held" dynamometer.

Control group

Breast cancer survivors without shoulder joint motion restriction

measurement of tissue stiffness (N/m)

Intervention Type OTHER

Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain

measurement of passive muscle tone (Hz)

Intervention Type OTHER

muscle tones will be measured with myotonPro on centers of coordination located along along the myofascial chain

measurement of creep of tissue

Intervention Type OTHER

creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain

measurement of the range of shoulder joint motion

Intervention Type OTHER

The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.

measurement of skin temperature

Intervention Type OTHER

measurements will be taken by the thermographic camera

measurement of pain

Intervention Type OTHER

Pain will be evaluated by visual analog scale (VAS)

measurement of pain pressure threshold

Intervention Type OTHER

Pain pressure threshold will be evaluated by a digital algometer

measurement of grip strength

Intervention Type OTHER

The grip strength of both hand will be evaluated by "hand-held" dynamometer.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

measurement of tissue stiffness (N/m)

Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain

Intervention Type OTHER

measurement of passive muscle tone (Hz)

muscle tones will be measured with myotonPro on centers of coordination located along along the myofascial chain

Intervention Type OTHER

measurement of creep of tissue

creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain

Intervention Type OTHER

measurement of the range of shoulder joint motion

The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.

Intervention Type OTHER

measurement of skin temperature

measurements will be taken by the thermographic camera

Intervention Type OTHER

measurement of pain

Pain will be evaluated by visual analog scale (VAS)

Intervention Type OTHER

measurement of pain pressure threshold

Pain pressure threshold will be evaluated by a digital algometer

Intervention Type OTHER

measurement of grip strength

The grip strength of both hand will be evaluated by "hand-held" dynamometer.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women between the ages of 30-60
* Having breast cancer treatment within 5 years

Exclusion Criteria

* Not having agreed to participate in the study
* Presence of additional orthopedic (scoliosis, etc.), neurological (multiple sclerosis, stroke, etc.) and rheumatological diseases (ankylosing spondylitis, rheumatoid arthritis, etc.) that will affect upper extremity functions
Minimum Eligible Age

30 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul Medeniyet University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nilufer Kablan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

İstanbul Medeniyet University

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nilüfer Kablan, PhD

Role: CONTACT

+905067638556

Gülser Cinbaz, MSc

Role: CONTACT

+905558503576

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gülser Cinbaz

Role: primary

+905558502576

Study Documents

Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.

Document Type: Individual Participant Data Set

View Document

Document Type: Individual Participant Data Set

View Document

Document Type: Individual Participant Data Set

View Document

Document Type: Individual Participant Data Set

View Document

Document Type: Individual Participant Data Set

View Document

Document Type: Individual Participant Data Set

View Document

Document Type: Individual Participant Data Set

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022/0226

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.